Association between metabolic syndrome and liver histology among NAFLD patients without diabetes

Pushpjeet Kanwar, James E. Nelson, Katherine Yates, David E. Kleiner, Aynur Unalp-Arida, Kris V. Kowdley

Research output: Contribution to journalArticle

Abstract

Background: Metabolic syndrome (MetS) and obesity are associated with non-alcoholic fatty liver disease (NAFLD). The aim of this observational study was to examine the relationship of MetS and a diagnosis of non-alcoholic steatohepatitis (NASH) in patients without diabetes in the NASH Clinical Research Network (CRN). Methods: Clinical, demographic, histological, laboratory and anthropometric data were collected on 356 adult patients without diabetes with NAFLD. Obesity was defined as body mass index ≥30.0. MetS was determined using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATPIII) 2001 criteria to include 3 or more of the following: increased waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension and elevated fasting blood glucose. Results: Most patients were obese (71%) and had MetS (67%). Obesity was more prevalent among patients with MetS (80% vs 52%; p≤0.001). Markers of insulin resistance such as homoeostasis model assessment of insulin resistance (6.5 vs 4.9, p≤0.001) were higher among those with MetS compared with those without MetS. Histologically, patients without MetS had higher hepatocellular (p=0.04) and reticuloendothelial system iron (p=0.04). Patients with MetS were more likely to have severe hepatic steatosis (p=0.04) and chronic portal inflammation (p=0.01). On multiple logistic regression analysis, patients with definite NASH were almost 2.5 times more likely to have MetS than those without definite NASH (OR=2.41, p=0.01). Conclusions: MetS is common in patients without diabetes with NAFLD and is associated with greater insulin resistance, hepatic steatosis and portal inflammation. While patients without MetS have greater iron overload, patients with MetS may have an increased propensity to have NASH. Therefore, presence of MetS in patients without diabetes with NAFLD may serve as a potential criterion for liver biopsy. Trial registration number: NCT00063622; Pre-results.

Original languageEnglish (US)
Article numbere000114
JournalBMJ Open Gastroenterology
Volume3
Issue number1
DOIs
StatePublished - Dec 31 2016

Fingerprint

Histology
Liver
Fatty Liver
Insulin Resistance
Obesity
Non-alcoholic Fatty Liver Disease
Inflammation
Mononuclear Phagocyte System
Iron Overload
Waist Circumference
HDL Cholesterol
Observational Studies
Blood Glucose
Fasting
Triglycerides
Body Mass Index
Homeostasis
Iron
Logistic Models
Cholesterol

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. / Kanwar, Pushpjeet; Nelson, James E.; Yates, Katherine; Kleiner, David E.; Unalp-Arida, Aynur; Kowdley, Kris V.

In: BMJ Open Gastroenterology, Vol. 3, No. 1, e000114, 31.12.2016.

Research output: Contribution to journalArticle

Kanwar, Pushpjeet ; Nelson, James E. ; Yates, Katherine ; Kleiner, David E. ; Unalp-Arida, Aynur ; Kowdley, Kris V. / Association between metabolic syndrome and liver histology among NAFLD patients without diabetes. In: BMJ Open Gastroenterology. 2016 ; Vol. 3, No. 1.
@article{ecb598445d7540ec91f80628fd252437,
title = "Association between metabolic syndrome and liver histology among NAFLD patients without diabetes",
abstract = "Background: Metabolic syndrome (MetS) and obesity are associated with non-alcoholic fatty liver disease (NAFLD). The aim of this observational study was to examine the relationship of MetS and a diagnosis of non-alcoholic steatohepatitis (NASH) in patients without diabetes in the NASH Clinical Research Network (CRN). Methods: Clinical, demographic, histological, laboratory and anthropometric data were collected on 356 adult patients without diabetes with NAFLD. Obesity was defined as body mass index ≥30.0. MetS was determined using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATPIII) 2001 criteria to include 3 or more of the following: increased waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension and elevated fasting blood glucose. Results: Most patients were obese (71{\%}) and had MetS (67{\%}). Obesity was more prevalent among patients with MetS (80{\%} vs 52{\%}; p≤0.001). Markers of insulin resistance such as homoeostasis model assessment of insulin resistance (6.5 vs 4.9, p≤0.001) were higher among those with MetS compared with those without MetS. Histologically, patients without MetS had higher hepatocellular (p=0.04) and reticuloendothelial system iron (p=0.04). Patients with MetS were more likely to have severe hepatic steatosis (p=0.04) and chronic portal inflammation (p=0.01). On multiple logistic regression analysis, patients with definite NASH were almost 2.5 times more likely to have MetS than those without definite NASH (OR=2.41, p=0.01). Conclusions: MetS is common in patients without diabetes with NAFLD and is associated with greater insulin resistance, hepatic steatosis and portal inflammation. While patients without MetS have greater iron overload, patients with MetS may have an increased propensity to have NASH. Therefore, presence of MetS in patients without diabetes with NAFLD may serve as a potential criterion for liver biopsy. Trial registration number: NCT00063622; Pre-results.",
author = "Pushpjeet Kanwar and Nelson, {James E.} and Katherine Yates and Kleiner, {David E.} and Aynur Unalp-Arida and Kowdley, {Kris V.}",
year = "2016",
month = "12",
day = "31",
doi = "10.1136/bmjgast-2016-000114",
language = "English (US)",
volume = "3",
journal = "BMJ Open Gastroenterology",
issn = "2054-4774",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Association between metabolic syndrome and liver histology among NAFLD patients without diabetes

AU - Kanwar, Pushpjeet

AU - Nelson, James E.

AU - Yates, Katherine

AU - Kleiner, David E.

AU - Unalp-Arida, Aynur

AU - Kowdley, Kris V.

PY - 2016/12/31

Y1 - 2016/12/31

N2 - Background: Metabolic syndrome (MetS) and obesity are associated with non-alcoholic fatty liver disease (NAFLD). The aim of this observational study was to examine the relationship of MetS and a diagnosis of non-alcoholic steatohepatitis (NASH) in patients without diabetes in the NASH Clinical Research Network (CRN). Methods: Clinical, demographic, histological, laboratory and anthropometric data were collected on 356 adult patients without diabetes with NAFLD. Obesity was defined as body mass index ≥30.0. MetS was determined using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATPIII) 2001 criteria to include 3 or more of the following: increased waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension and elevated fasting blood glucose. Results: Most patients were obese (71%) and had MetS (67%). Obesity was more prevalent among patients with MetS (80% vs 52%; p≤0.001). Markers of insulin resistance such as homoeostasis model assessment of insulin resistance (6.5 vs 4.9, p≤0.001) were higher among those with MetS compared with those without MetS. Histologically, patients without MetS had higher hepatocellular (p=0.04) and reticuloendothelial system iron (p=0.04). Patients with MetS were more likely to have severe hepatic steatosis (p=0.04) and chronic portal inflammation (p=0.01). On multiple logistic regression analysis, patients with definite NASH were almost 2.5 times more likely to have MetS than those without definite NASH (OR=2.41, p=0.01). Conclusions: MetS is common in patients without diabetes with NAFLD and is associated with greater insulin resistance, hepatic steatosis and portal inflammation. While patients without MetS have greater iron overload, patients with MetS may have an increased propensity to have NASH. Therefore, presence of MetS in patients without diabetes with NAFLD may serve as a potential criterion for liver biopsy. Trial registration number: NCT00063622; Pre-results.

AB - Background: Metabolic syndrome (MetS) and obesity are associated with non-alcoholic fatty liver disease (NAFLD). The aim of this observational study was to examine the relationship of MetS and a diagnosis of non-alcoholic steatohepatitis (NASH) in patients without diabetes in the NASH Clinical Research Network (CRN). Methods: Clinical, demographic, histological, laboratory and anthropometric data were collected on 356 adult patients without diabetes with NAFLD. Obesity was defined as body mass index ≥30.0. MetS was determined using the National Cholesterol Education Program-Adult Treatment Panel III (NCEP ATPIII) 2001 criteria to include 3 or more of the following: increased waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension and elevated fasting blood glucose. Results: Most patients were obese (71%) and had MetS (67%). Obesity was more prevalent among patients with MetS (80% vs 52%; p≤0.001). Markers of insulin resistance such as homoeostasis model assessment of insulin resistance (6.5 vs 4.9, p≤0.001) were higher among those with MetS compared with those without MetS. Histologically, patients without MetS had higher hepatocellular (p=0.04) and reticuloendothelial system iron (p=0.04). Patients with MetS were more likely to have severe hepatic steatosis (p=0.04) and chronic portal inflammation (p=0.01). On multiple logistic regression analysis, patients with definite NASH were almost 2.5 times more likely to have MetS than those without definite NASH (OR=2.41, p=0.01). Conclusions: MetS is common in patients without diabetes with NAFLD and is associated with greater insulin resistance, hepatic steatosis and portal inflammation. While patients without MetS have greater iron overload, patients with MetS may have an increased propensity to have NASH. Therefore, presence of MetS in patients without diabetes with NAFLD may serve as a potential criterion for liver biopsy. Trial registration number: NCT00063622; Pre-results.

UR - http://www.scopus.com/inward/record.url?scp=85038941493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038941493&partnerID=8YFLogxK

U2 - 10.1136/bmjgast-2016-000114

DO - 10.1136/bmjgast-2016-000114

M3 - Article

AN - SCOPUS:85038941493

VL - 3

JO - BMJ Open Gastroenterology

JF - BMJ Open Gastroenterology

SN - 2054-4774

IS - 1

M1 - e000114

ER -